Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2024 07:00 ET | Source: Kanglin Biotec

Kanglin Biotechnology Announces $20 Million Series A Financing to Advance the Development of Gene Therapies

- Phase 1 study and Investigator Initiated Trial evaluating KL003 for patients with beta thalassemia demonstrated an encouraging efficacy signal and favorable safety profile – - Manufacturing costs...